Publications by authors named "E Lengline"

Claim this Profile
L
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.
Manon Delafoy, Mickaël F Bonnet, Etienne Lengliné, Agata Cieslak, Aurore Touzart

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Simultaneous Quantification Method for 12 Targeted Therapies and 3 Active Metabolites in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry: An Application to Therapeutic Drug Monitoring in Patients With Hematological Malignancies.
Nicolas Vignal, Marie Allard, Sofiane Fodil, Etienne Lengline, Hélène Sauvageon

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.
Romain Stammler, Alexandre Vallée, Julien Rohmer, Nathalie Grardel, Noémie Abisror, Etienne Lengline

J Allergy Clin Immunol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses.
Natacha Kapandji, Maud Salmona, Anaïs Lemoine, Guillaume Ulmann, Julien Calderaro, Etienne Lengline

Exp Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer.
Guillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, Etienne Lengliné, Ambroise Marçais

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis